Patents by Inventor Donald Elmerick

Donald Elmerick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-invasive glucose measuring device and method for measuring blood glucose
    Patent number: 6775564
    Abstract: A glucose measuring device for determining the concentration of glucose in intravascular blood within a body part of a subject. The device includes at least one light source having a wavelength of 650, 880, 940 or 1300 nm to illuminate the fluid. At least one receptor (14) associated with the light source (12) for receiving light and generating a transmission signal representing the light transmitted is also provided. A support piece is including for supporting the light source associated with the respective receptor. The support piece is adapted to engage a body part of a subject. Finally, a signal analyzer determines the glucose concentration in the blood of the subject. A method for determining the glucose concentration is also provided which calibrates a measuring device and sets the operating current for illuminating the light sources during operation of the device.
    Type: Grant
    Filed: August 12, 1999
    Date of Patent: August 10, 2004
    Assignee: LifeTrac Systems, Inc.
    Inventors: Richard K. Peters, Donald Elmerick
  • Non-invasive glucose measuring device and method for measuring blood glucose
    Patent number: 5910109
    Abstract: A glucose measuring device for determining the concentration of glucose in intravascular blood within a body part of a subject. The device includes light sources having a wavelength of 650, 880, 940 or 1300 nm to illuminate the fluid. Receptors associated with the light sources for receiving light and generating a transmission signal representing the light transmitted are also provided. A support piece is including for supporting the light sources associated with their respective light sources. The support piece is adapted to engage a body part of a subject. Finally, a signal analyzer, which includes a trained neural network, determines the glucose concentration in the blood of the subject. A method for determining the glucose concentration is also provided which calibrates a measuring device and sets the operating current for illuminating the light sources during operation of the device.
    Type: Grant
    Filed: February 20, 1997
    Date of Patent: June 8, 1999
    Assignee: Emerging Technology Systems, LLC
    Inventors: Richard K. Peters, Donald Elmerick
  • Needle disintegration device method and apparatus
    Patent number: 5300752
    Abstract: A method and apparatus for disintegrating and otherwise destroying a syringe needle through total and complete incineration.
    Type: Grant
    Filed: May 7, 1993
    Date of Patent: April 5, 1994
    Inventors: Donald Elmerick, Richard Peters